ISSN: 1755-5310 (Electronic)1755-5302 (Print)

Interventional Cardiology

Heart Failure Scholarly Peer-review Journal

Treatment depends on the severity and explanation for the disease. In people with chronic stable mild coronary failure, treatment commonly consists of lifestyle modifications like stopping smoking, workout, and dietary changes, also as medications. In those with coronary failure thanks to left ventricular dysfunction, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or valsartan/sacubitril alongside beta blockers is recommended. For those with severe disease, aldosterone antagonists, or hydralazine with a nitrate could also be used. In some moderate or severe cases, cardiac resynchronization therapy (CRT) or cardiac contractility modulation could also be of benefit. A ventricular assist device (for the left, right, or both ventricles), or occasionally a heart transplant may be recommended in those with severe disease that persists despite all other measures. Heart failure may be a common, costly, and potentially fatal condition. In 2015, it affected about 40 million people globally. Overall around 2% of adults have coronary failure and in those over the age of 65, this increases to 6–10%. Rates are predicted to increase. The risk of death is about 35% the primary year after diagnosis, while by the second year the danger of death is a smaller amount than 10% for those that remain alive. This degree of risk of death is similar to some cancers.

High Impact List of Articles

Relevant Topics in Clinical